Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells

International Journal of Cancer

Volumn 114, Issue 1, 2005, Pages 1-11

  Harmand, Pierre Olivier ^a   Duval, Raphaël ^a   Delage, Christiane ^a   Simon, Alain ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

m; Apoptosis; Bax Bcl2; Caspases; M4Beu; Mitochondria; Ursolic acid

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; PROTEIN BAX; PROTEIN BCL 2; TRITERPENE DERIVATIVE; URSOLIC ACID;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EFFECTOR CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL INTRINSIC PATHWAY; MITOCHONDRION; PLEIOTROPY; PRIORITY JOURNAL; PUBLIC HEALTH; SKIN CANCER; SKIN PROTECTION; STATISTICAL SIGNIFICANCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLIC ACIDS; ENZYME ACTIVATION; FLAVOPROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MEMBRANE PROTEINS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 13244255330     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20588     Document Type: Article

References (54)

1. Menegoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buemi A, Carli PM, Chapelain G, Faivre J, Gignoux M, Grosclaude P, Mace-Lesec'h J, et al. Cancer incidence and mortality in France in 1975-1995. Eur J Cancer Prev 1997;6:442-66.
2. Muir C, Waterhouse J, Mack T. Cancer incidence in five continents. Lyon: IARC, 1987.
3. Roush GC, Schymura MJ, Holdford TR. Patterns of invasive melanoma in the Connecticut tumor registry: is the long-term increase real? Cancer 1988;61:2586-95.
4. Thomas L, Tranchand P, Berard F, Secchi T, Colin C, Moulin G. Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors. Dermatology 1998;197:11-7.
5. Mahato SB, Sarkar SK, Poddar G. Triterpenoid saponins. Phytochemistry 1988;27:3037-67.
6. Belding RD, Blankenship SM, Young E, Leidy RB. Composition and variability of epicuticular waxes in apple cultivars. J Am Soc Hort Sci 1998;123:348-56.
7. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995;49:57-68.
8. Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M, Park BC, Kim KW. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res 1996;56:2281-4.
9. Both DM, Goodtzova K, Yarosh DB, Brown DA. Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells. Arch Dermatol Res 2002;293:569-75.
10. Yarosh DB, Both D, Brown D. Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin. Horm Res 2000;54:318-21.
11. Harmand PO, Duval R, Liagre B, Jayat-Vignoles C, Beneytout JL, Delage C, Simon A. Ursolic acid induces apoptosis through caspase-3 activation and cell cycle arrest in HaCat cells. Int J Oncol 2003;23:105-12.
12. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
13. Green DR. Apoptotic pathways: the roads to ruin. Cell 1998;94:695-8.
14. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
15. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.
16. Gupta S, Radha V, Sudhakar Ch, Swarup G. A nuclear protein tyrosine phosphatase activates p53 and induces caspase-1-dependent apoptosis. FEES Lett 2002;532:61-6.
17. Metzstein MM, Stanfield GM, Horvitz HR. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet 1998;14:410-6.
18. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6.
19. Meier P, Finch A, Evan G. Apoptosis in development. Nature 2000;407:796-801.
20. Schultz DR, Harrington WJ Jr. Apoptosis programmed cell death at a molecular level. Semin Arthritis Rheum 2003;32:345-69.
21. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926-30.
22. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6.
23. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterry I, Castedo M, Kroemer G. Mitochondrial control of nuclear apoptosis. J Exp Med 1996;181:1533-44.
24. Fridman JS, Benedict MA, Maybaum J. Bcl-X(S)-induced cell death in 3T3 cells does not require or induce caspase activation. Cancer Res 1999;59:5999-6004.
25. Yang J, Liu X, Bhalla, K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-32.
26. Debiton E, Cussac-Buchdhal C, Mounetou E, Rapp M, Dupuy JM, Maurizis JC, Veyre A, Madelmont JC. Enhancement by O6-benzyl-N2-acetylguanosine of N′-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N′-nitrosourea therapeutic index on nude mice bearing resistant human melanoma. Br J Cancer 1997;7:1157-62.
27. Boukerche H, Benchaibi M, Berthier-Vergnes O, Lizard G, Bailly M, Bailly M, McGregor JL. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit. Eur J Biochem 1994;220:485-91.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
29. Duval R, Delebassée S, Cardot PJ, Bosgiraud C. Visna virus-induced cytopathic effect in vitro is caused by apoptosis. Arch Virol 2002;147:943-59.
30. Duval R, Bellet V, Delebassee S, Bosgiraud C. Implication of caspases during maedi-visna virus-induced apoptosis. J Gen Virol 2002;83:3153-61.
31. Zuliani T, Duval R, Jayat C, Schnebert S, Andre P, Dumas M, Ratinaud MH. Sensitive and reliable JC-1 and TOTO-3 double staining to assess mitochondrial transmembrane potential and plasma membrane integrity: interest for cell death investigations. Cytometry 2003;54:100-8.
32. 2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int J Cancer 1997;73:725-8.
33. Lauthier F, Taillet L, Trouillas P, Belage C, Simon A. Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anticancer Drugs 2000;11:737-45.
34. Hollosy F, Idei M, Csorba G, Szabo E, Bokonyi G, Seprodi A, Meszaros G, Szende B, Keri G. Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis. Anticancer Res 2001;21:3485-91.
35. Andersson D, Liu JJ, Nilsson A, Duan RD. Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res 2003;23:3317-22.
36. Es-Saady D, Simon A, Jayat-Vignoles C, Chulia AJ, Delage C. MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts. Anticancer Res 1996;16:481-6.
37. Lee I, Lee J, Lee YH, Leonard J. Ursolic acid-induced changes in tumor growth, O2 consumption, and tumor interstitial fluid pressure. Anticancer Res 2001;21:2827-33.
38. Pagliacci MC, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F, Riccardi C, Nicoletti I. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur J Cancer 1993;29:1573-7.
39. Hollosy F, Meszaros G, Bokonyi G, Idei M, Seprodi A, Szende B, Keri G. Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells. Anticancer Res 2000;20:4563-70.
40. Mizushina Y, Iida A, Ohta K, Sugawara F, Sakaguchi K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem J 2000;350:757-63.
41. Es-Saady D, Simon A, Ollier M, Maurizis JC, Chulia AJ, Delage C. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett 1996;106:193-7.
42. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers FC, Bjorklund B, Nap M, Jornvall H, Schutte B. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 1999;187:567-72.
43. Szmit E, Trzonkowski P, Mysliwska J, Foester J, Mysliwski A. Ex vivo apoptotic potential of peripheral blood mononuclear cells of the elderly human subject. Cell Biol Int 2002;26:517-27.
44. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
45. Devireddy L, Jones CJ. Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release. J Virol 1999;73:3778-88.
46. Katayose D, Wersto R, Cowan K, Seth P. Consequence of p53 gene expression by adenovirus vector on cell cycle arrest and apoptosis in human aortic vascular smooth muscle cells. Biochem Biophys Res Commun 1995;215:446-51.
47. Chen YC, Lin-Shiau SY, Lin JK. Involvement of heat-shock protein 70 and p53 proteins in attenuation of UVC-induced apoptosis by thermal stress in hepatocellular carcinoma cells. Photochem Photobiol 1999;70:78-86.
48. Kroemer G. Introduction: mitochondrial control of apoptosis. Biochimie 2002;84:103-4.
49. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loefler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med 2000;192:571-80.
50. Arnoult D, Parone P, Martinou JC, Antonsson B, Estaquier J, Ameinsen JC. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 2002;159:923-9.
51. Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, Youle RJ. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003;22:4385-99.
52. Kroemer G. Heat shock protein 70 neutralizes apoptosis-inducing factor. Sci World J 2001;1:590-2.
53. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong HH, Kinghorn AD, Brown DM. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1995;1:1046-51.
54. Tan Y, Yu R, Pezzuto JM. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin Cancer Res 2003;9:2866-75.